Superior, clean protein: Next-generation BLG whey, ultra-filtered to remove fat and lactose together with boosted leucine and a superior amino acid profile
Healthcare providers bear responsibility for discussing potential ocular complications during the prescribing process, ensuring patients recognize warning signs and understand their individual risk profile
In this scenario, pending the best possible clarification of the understanding of the different FM phenotypes based on specific pathophysiologic features, we sought to reach a consensus among neurologists on the most appropriate treatment for FM based on a review of recent RCTs in the field of pharmacologic and non-pharmacologic treatments
Commenters recommended that CMS engage in ongoing monitoring of payment adequacy as more data is gathered on this service over time
The goal is not to avoid combination therapy
The new Medicare GLP-1 Bridge gives eligible Part D beneficiaries access to certain GLP-1 weight-loss medications for $50 per month